H. A. Hong

发表

Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine.

Y. K. Choi, Y. Choi, M. Song, 2012, Vaccine.

Defining the natural habitat of Bacillus spore-formers.

E. Ricca, L. Baccigalupi, S. Cutting, 2009, Research in microbiology.

Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles.

S. Cutting, H. A. Hong, N. Q. Uyển, 2007, Vaccine.

Intracellular fate and immunogenicity of B. subtilis spores.

S. Cutting, H. A. Hong, N. Q. Uyển, 2004, Vaccine.

Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner.

Emilia M F Mauriello, R. Isticato, M. De Felice, 2004, Vaccine.

Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery.

S. Cutting, H. A. Hong, L. H. Duc, 2003, Vaccine.

The Intestinal Life Cycle of Bacillus subtilis and Close Relatives

A. Henriques, C. Serra, S. Cutting, 2006, Journal of bacteriology.

Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile

A. Wilkinson, S. Cutting, Siamand Hosseini, 2017, Infection and Immunity.

Oral Vaccine Delivery by Recombinant Spore Probiotics

E. Ricca, L. Baccigalupi, S. Cutting, 2009, International reviews of immunology.

Inducible Expression of spo0A as a Universal Tool for Studying Sporulation in Clostridium difficile

S. Cutting, Siamand Hosseini, H. A. Hong, 2017, Front. Microbiol..

The Spore Coat Protein CotE Facilitates Host Colonization by Clostridium difficile

J. Zentek, A. Wilkinson, W. Vahjen, 2017, The Journal of infectious diseases.

Protection of Penaeus monodon against white spot syndrome by continuous oral administration of a low concentration of Bacillus subtilis spores expressing the VP28 antigen

S. Cutting, H. A. Hong, T. Phan, 2017, Letters in applied microbiology.

Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model.

R. Reljic, S. Cutting, H. A. Hong, 2014, FEMS microbiology letters.

Bacterial Spores as Vaccine Vehicles

N. Fairweather, E. Ricca, S. Cutting, 2003, Infection and Immunity.

Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and B

N. Fairweather, S. Cutting, H. A. Hong, 2011, Infection and Immunity.

1 Mucosal Vaccination against TB Using Inert Bioparticles 2

R. Reljic, S. Cutting, H. A. Hong, 2013 .

The safety of Bacillus subtilis and Bacillus indicus as food probiotics

S. Cutting, H. A. Hong, Jen-Min Huang, 2008, Journal of applied microbiology.

Environmentally Acquired Bacillus and Their Role in C. difficile Colonization Resistance

J. Zentek, S. Cutting, H. A. Hong, 2022, Biomedicines.

Functional Characterization of Clostridium difficile Spore Coat Proteins

N. Fairweather, R. L. La Ragione, S. Cutting, 2013, Journal of bacteriology.

Evaluation of Bacillus subtilis strains as probiotics and their potential as a food ingredient.

S. Cutting, H. A. Hong, R. Khaneja, 2012, Beneficial microbes.

Safety and probiotic evaluation of two Bacillus strains producing antioxidant compounds.

A. Olender, S. Cutting, H. A. Hong, 2019, Beneficial microbes.

Recombinant Bacillus subtilis Expressing the Clostridium perfringens Alpha Toxoid Is a Candidate Orally Delivered Vaccine against Necrotic Enteritis

R. Titball, S. Cutting, H. A. Hong, 2008, Infection and Immunity.

Heterologous Systemic Prime–Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters

J. Segalés, J. Vergara-Alert, S. Cutting, 2022, Vaccines.

Intranasal Treatment of Ferrets with Inert Bacterial Spores Reduces Disease Caused by a Challenging H7N9 Avian Influenza Virus

S. Cutting, H. A. Hong, C. Dang, 2022, Vaccines.

Bacillus subtilis isolated from the human gastrointestinal tract.

A. Gasbarrini, I. Barnes, S. Cutting, 2009, Research in microbiology.

Characterization of Bacillus Probiotics Available for Human Use

A. Henriques, T. Barbosa, S. Cutting, 2004, Applied and Environmental Microbiology.

The use of bacterial spore formers as probiotics.

S. Cutting, H. A. Hong, L. H. Duc, 2005, FEMS microbiology reviews.

Mucosal delivery of antigens using adsorption to bacterial spores.

S. Cutting, H. A. Hong, Jen-Min Huang, 2010, Vaccine.

Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria

B. Wren, J. Swann, H. Kaur, 2018, PLoS pathogens.

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.

R. Titball, S. Rijpkema, H. Flick-Smith, 2007, Vaccine.

Micellar Antibiotics of Bacillus

E. Ricca, W. Meijer, L. Baccigalupi, 2021, Pharmaceutics.

Mucosal Vaccination against Tuberculosis Using Inert Bioparticles

R. Reljic, S. Cutting, H. A. Hong, 2013, Infection and Immunity.

The spore‐associated protein BclA1 affects the susceptibility of animals to colonization and infection by Clostridium difficile

N. Fairweather, Lluis Sempere, S. Cutting, 2014, Molecular microbiology.

Mucosal delivery of antigens using adsorption to bacterial spores.

S. Cutting, H. A. Hong, Jen-Min Huang, 2010, Vaccine.

Mucosal Vaccination against Tuberculosis Using Inert Bioparticles

R. Reljic, S. Cutting, H. A. Hong, 2013, Infection and Immunity.

Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines

S. Cutting, G. Christie, H. A. Hong, 2023, Helicobacter.